Symbols

TAK

Takeda Pharmaceutical·NYSE

--(--)

8.17 / 10

Outperform

The fund flow profile scores 8.17/10, demonstrating exceptionally strong fund flow dynamics. Favorable overall, block, Large, and Extra-large movements are tempered by challenging Small and Medium dynamics, supporting highly favorable flow assessment.

Fund Flow Rating

What is the analyst consensus for TAK?

TAK holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.17/10 (Outperform).